BioWorld MedTech

Sep. 6, 2016

After selling med-tech arm, Toshiba plans next-gen radiation therapy

TOKYO – Toshiba Corp. is developing a treatment for cancer that uses particle beams and will send the technology to trial next year, aiming to have a device on the market by the early 2020s. Read More

Senators make a push for incorporation of unique device identifiers into insurance claims forms

FDA hits Tosoh with third warning for U.S. operations since 2005

Ultrasound mobility device for the blind generating good vibrations in Canada

Other news to note

Appointments and advancements

Daily M&A

Financings

MDD's Cardiology Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 22, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 22, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...